A Model of Basement Membrane-Associated Gene Signature Predicts Liver Hepatocellular Carcinoma Response to Immune Checkpoint Inhibitors

Figure 4

Construction and verification of the BMRG risk model by LASSO Cox regression analysis. (a–c) The Kaplan-Meier curves for patients with the high- and low-BMRG subgroups: (a) train cohort, (b) test cohort, and (c) ICGC cohort. (d–f) ROC curves showing the predictive efficiency of the BMRG risk scores for 1-year, 3-year, and 5-year survival: (d) train set, (e) test set, and (f) ICGC validation set. (g) Univariate analysis of risk scores of BMRGs and clinicopathological characteristics of LIHC. (h) Multivariate analysis of risk scores of BMRGs and clinicopathological characteristics of LIHC.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)